Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
INDIA'S smaller generic drugmakers, struggling to cope with a bruised reputation and tougher regulation in the United States, are under pressure to consider branching out to new, less-profitable markets or sell out to larger rivals.
Two years after its most high-profile